The physiological impact of mad honey is not confined to a single organ system. Grayanotoxins, by virtue of their action on voltage-gated sodium channels expressed across multiple tissue types, produce a constellation of effects spanning the cardiovascular system, the autonomic nervous system, the peripheral sensory nervous system, and the gastrointestinal tract. Understanding each system’s contribution to the overall clinical picture is essential for interpreting the spectrum of severity seen in different patients and for understanding why the toxidrome responds to specific interventions.
Key Takeaways
- Grayanotoxins affect cardiac, vascular, autonomic, sensory, and gastrointestinal physiology through Nav channel modulation at multiple tissue-specific subtypes.
- Bradycardia results from both direct Nav1.5 depression of SA node automaticity and reflexive vagal M2 activation — the dual mechanism explains atropine’s clinical effectiveness.
- Hypotension reflects both reduced cardiac output (from bradycardia) and direct vascular smooth muscle depolarisation-mediated vasodilation.
- Perioral paraesthesia is an early symptom reflecting high Nav subtype density in trigeminal sensory fibres at the site of initial mucosal contact.
- Recovery is complete and time-limited, reflecting non-covalent binding and pharmacokinetics of grayanotoxin elimination — no permanent channel modification occurs.
Cardiac Physiology: The SA and AV Nodes
The sinoatrial (SA) node — the heart’s primary pacemaker — generates the rhythmic electrical impulses that set the heart rate. Its automaticity depends on a coordinated sequence of ion channel activities, including sodium (Nav1.5 in cardiac tissue), calcium (Cav1.3), and potassium channel currents. Grayanotoxin binding to Nav1.5 at the SA node prevents the normal rapid repolarisation that allows the pacemaker cycle to reset. The result is a prolonged action potential duration in pacemaker cells and reduced frequency of spontaneous depolarisation — manifesting as bradycardia.
The atrioventricular (AV) node conducts electrical impulses from the atria to the ventricles and imposes a normal delay (the PR interval) to allow atrial contraction to complete before ventricular activation. Grayanotoxin-induced sodium channel dysfunction at the AV node slows conduction further, prolonging the PR interval (first-degree AV block) and, at higher doses or in susceptible individuals, producing intermittent or complete failure of AV conduction (second- or third-degree AV block). These graded conduction abnormalities correspond to the spectrum of ECG findings documented in clinical case series.
Myocardial contractility is also affected, though less dramatically than rate and conduction in most clinical cases. Sustained sodium influx through persistently open Nav1.5 channels can trigger secondary calcium entry via reverse Na/Ca exchanger activity, potentially contributing to a transient calcium overload state. This mechanism, more prominent at higher grayanotoxin concentrations, may account for the occasional reports of hyperdynamic then hypodynamic states in severe animal studies, though in human clinical cases, haemodynamic compromise appears primarily rate-dependent rather than contractility-dependent.
Vascular Physiology: Hypotension and Vasodilation
Blood pressure is maintained by the interaction of cardiac output (heart rate × stroke volume) and systemic vascular resistance. Grayanotoxin-induced bradycardia reduces cardiac output directly through rate reduction. Simultaneously, grayanotoxins act on NaV channels in vascular smooth muscle cells, producing membrane depolarisation that, paradoxically, can lead to either vasoconstriction (at very high, pharmacological depolarisation) or functional vasodilation (through Na/Ca exchanger reversal, reducing intracellular calcium availability for smooth muscle contraction).
The net vascular effect in most clinical presentations is vasodilation and hypotension — consistent with the dominant observation of low blood pressure accompanying bradycardia. This contrasts with the haemodynamic picture of most other causes of bradycardia (such as beta-blocker overdose, where hypotension may be less prominent). The combined reduction in cardiac output and loss of vascular tone produces a haemodynamic profile that, at its most severe, approaches distributive shock — responsive to both atropine (which increases heart rate) and IV fluid resuscitation (which supports preload).
Autonomic Nervous System: Vagal Overdrive
The autonomic contribution to grayanotoxin physiology is substantial and mechanistically distinct from the direct ion channel effects. Grayanotoxins activate sodium channels in vagal afferent (sensory) nerve fibres — the primary afferents that carry sensory information from the heart, great vessels, lungs, and gastrointestinal tract to the nucleus tractus solitarius in the brainstem. This activation is interpreted by central autonomic circuits as a signal requiring parasympathetic (vagal) upregulation.
The efferent consequence is increased vagal (cholinergic) tone to the heart, mediated through muscarinic M2 receptors on the SA and AV nodes. This vagal overdrive amplifies the direct sodium channel effect on pacemaker automaticity and conduction, compounding the bradycardia. The dual mechanism — direct Nav1.5 effect plus reflexive vagal M2 activation — explains why atropine (an M2 muscarinic antagonist) is so effective in this setting despite having no direct action on sodium channels. By blocking the muscarinic receptor component of the bradycardia, atropine removes the reflexive amplification, often restoring adequate heart rate even before any grayanotoxin clearance occurs.
Vagal overdrive also contributes to the gastrointestinal features of the toxidrome. Vagal efferent pathways increase gastrointestinal secretion and motility, producing the hypersalivation, nausea, and sometimes vomiting that characterise the early symptom onset. The sequence of GI symptoms preceding cardiovascular symptoms in some cases likely reflects the faster vasoactive response of vagal afferent activation compared to the slightly slower direct cardiac sodium channel effect.
Peripheral Sensory Nervous System: Paraesthesia
Peripheral sensory neurons express multiple Nav subtypes — Nav1.7, Nav1.8, and Nav1.9 in nociceptive and thermoreceptive fibres; Nav1.6 in Aβ mechanoreceptor afferents. Grayanotoxin activity at these subtypes produces the paraesthesia (tingling, numbness) characteristically described as perioral and then spreading to the extremities in clinical cases. The perioral distribution likely reflects the high density of trigeminal sensory fibres at the lips and mouth — the first tissues in contact with high concentrations of ingested grayanotoxin before systemic absorption is complete.
The paraesthesia of grayanotoxin poisoning is mechanistically analogous to the sensory effects of other site 2 sodium channel toxins, and to the opposite effect of Nav1.7-blocking compounds (which have been explored as analgesics). Sodium channel activation rather than blockade produces the tingling and numbness because the sustained depolarisation of sensory neuron membranes puts them in a state of reduced ability to generate normal action potentials — a paradoxical inhibition of sensory signalling through over-excitation.
Gastrointestinal Physiology
Grayanotoxins have a direct effect on gastrointestinal smooth muscle (which expresses Nav channels, primarily Nav1.5 and Nav1.4-related subtypes) and an indirect effect through vagal activation. The direct smooth muscle effect involves membrane depolarisation and altered contraction dynamics. The clinical result is nausea, and in some cases vomiting and diarrhoea, appearing early in the symptomatic course.
Hypersalivation — reported in a significant proportion of symptomatic cases — reflects vagal stimulation of salivary gland secretion and is a useful early clinical indicator of significant grayanotoxin absorption. Its presence alongside perioral tingling and nausea constitutes a prodrome that, in the context of a honey consumption history, should prompt anticipation of cardiovascular effects developing over the subsequent 30–60 minutes.
Resolution Physiology
Grayanotoxin effects are reversible because the compound is metabolised and excreted without producing permanent modification of sodium channel structure. The binding is non-covalent; as plasma concentrations fall through hepatic metabolism and renal excretion, the channel population progressively returns to normal function. The time course of recovery — typically 6–24 hours for spontaneous resolution in non-severe cases — reflects the pharmacokinetics of grayanotoxin elimination rather than any tissue repair process. This self-limiting nature is the basis for the good prognosis of grayanotoxin poisoning in healthy adults when appropriately supported.
